Kiniksa Pharmaceuticals International, plc (KNSA) stock
KNSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 14/30469% above fair value
$95.11+0.88 (+0.93%)
Close on Nov 17, 2026Market cap $14.95BP/E 73.2Yield –
Kiniksa Pharmaceuticals International EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Kiniksa Pharmaceuticals International's EV/EBITDA was 71.7× on Nov 11, 2026, against 73.3× a year earlier. Over the last 2 years it ranged from 22.1× to 432.7×, with a median of 49.4×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 71.7× | +0.9 |
| 2025 | Dec 31, 2025 | 70.8× | +48.7 |
| 2023 | Oct 31, 2023 | 22.1× | – |
See a number that looks wrong?